TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 7.8 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS

Julian Panés  1     Bruce E. Sands  2     Remo Panaccione  3     Nervin Lawendy  4     nicole kulisek  4     Xiang Guo  4     Rajiv Mundayat  5     Chinyu Su     Geert R. D'Haens     William J. Sandborn     Siew C. Ng    
1 Hospital Clínic de Barcelona, IDIBAPS, CIBERehd,Barcelona,Spain
2 Dr. Henry D. Janowitz Division of Gastroenterology,New York, NY,United States
3 University of Calgary,Calgary, AB,Canada
4 Pfizer Inc,Collegeville, PA,United States
5 Pfizer Inc,New York,

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing